Urai Shin, Hashimoto Naoko, Takabe Michinori, Kashitani Yuya, Satake Yuka, Nishimoto Yuki, Kawashima Motoharu, Henmi Soichiro, Kuroda Mitsuo, Yamane Yu, Koga Tokito, Kajita Satoru, Doi Kazuki, Oue Tetsuya, Murakami Hirohisa, Mukohara Nobuhiko, Ohara Takeshi
Perioperative hyperglycemia, hypoglycemia, and high glycemic variability are independent risk factors for mortality in critically ill patients. After cardiac surgery, intensive glycemic control without hypoglycemia may help to reduce the number of adverse events; however, postoperative glycemic control is difficult in many cases. In this study, we investigated whether the bedside artificial pancreas STG-55 is useful for postoperative glycemic control in cardiac surgery. METHODS: In the present single-center retrospective study, we analyzed arterial blood glucose levels for 15 h after surgery in 69 patients treated using the bedside artificial pancreas and in 160 patients treated with continuous intravenous insulin infusion using a scale that adjusts for current blood glucose level, glycemic fluctuation, and insulin dose...
June 2021: Journal of Artificial Organs: the Official Journal of the Japanese Society for Artificial Organs